Exciting Launch of CLERIVY’s K-Beauty Pimple Patches on Amazon
August 25, 2026, marks a significant milestone for Korean skincare brand CLERIVY as it makes its grand entrance into the U.S. market with two innovative cosmetic patches now available on Amazon.com. This debut includes their Hydrocolloid Pimple Patch and the Microdart Spot Patch, crafted to target various stages of acne effectively.
CLERIVY, founded by Guhada Co., Ltd., is bringing the essence of K-Beauty to the forefront of the American skincare market. The Hydrocolloid Pimple Patch serves as a protective barrier for existing blemishes, while the Microdart Spot Patch aims to prevent future breakouts by treating bumps that are forming below the skin surface. Incredibly, a third product, the Microdart Acne Patch, is set to follow suit with a release scheduled for October 2026. This patch has received FDA status as an over-the-counter (OTC) monograph drug for acne treatment, boasting a potent 2% salicylic acid formulation.
Detailed Look at the Products
The
Microdart Spot Patch is designed specifically for treating those pesky bumps you often feel before they become visible. It utilizes a novel formulation that includes:
- - 7% Niacinamide
- - 3% Tranexamic Acid
- - 2.7% Sodium Ascorbyl Phosphate (a form of Vitamin C)
This blend aims not only to address acne but also to assist in skin conditioning and reducing the appearance of post-blemish marks. Furthermore, the patch includes less than 0.5% salicylic acid solely for cosmetic use, supporting the targeted treatment approach. With a three-part strategy, CLERIVY emphasizes early intervention, skin conditioning, and targeted healing to achieve optimal skin clarity.
Once blemishes surface, users can rely on the
Hydrocolloid Pimple Patch for additional care. This patch likewise incorporates less than 0.5% salicylic acid for cosmetic purposes and features an advanced mix of skin-conditioning ingredients, including phytosphingosine, panthenol, and allantoin. It can be kept on the skin for four to eight hours, offering a barrier that absorbs impurities and aids in both healing and protection.
It’s vital to mention that both these products are categorized as cosmetics, rather than drugs, ensuring they are accessible for use without a prescription.
Proven Efficacy and Safety
CLERIVY has ensured that the Hydrocolloid Pimple Patch is suitable for sensitive skin, having conducted rigorous testing through Cutis Biomedical Research Center Co., Ltd. The patch showed a statistically significant improvement in redness reduction, with a noted 14.5% decrease. Participants rated the product favorably, averaging a score of 4.4 out of 5 for usability in a survey concerning sensitive skin.
Upcoming Releases
Looking ahead, the
Microdart Acne Patch is poised to become an essential product for acne treatment in the United States. Registered under OTC Monograph M006, its Drug Facts label highlights salicylic acid as its primary active ingredient, reinforcing CLERIVY's commitment to transparency in product formulation. Its additional components, including niacinamide and tranexamic acid, reinforce its efficacy and user safety profile.
Available in varying pack sizes—including 10 mm and 12 mm options for the Hydrocolloid Patch—CLERIVY strives to cater to diverse consumer preferences. The company plans to expand its offerings in the U.S. beyond these patches, with serums and creams expected to follow after the October launch.
A Bright Future for CLERIVY
Yoon Jae-sub, CEO of Guhada, lauded the brand's initial U.S. patch lineup, emphasizing their goal of addressing unmet skincare needs and building a market presence through high-quality products, deeply rooted in advanced manufacturing. CLERIVY’s approach, focusing on individual skin needs and transparency, aligns seamlessly with the growing trends in the beauty industry.
To discover more about CLERIVY and its range of skincare solutions, potential customers are encouraged to visit
clerivy.com.
In conclusion, CLERIVY's introduction of K-Beauty pimple patches represents not just an innovation in skincare but also a response to a significant consumer demand in the U.S. market, reflecting the brand’s commitment to understanding and fulfilling the diverse needs of individuals seeking effective acne treatment in a competitive landscape.